Gene · 4082
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion. | Mol Cell Proteomics | 2020 | 31678930 | PubTator, text mining | PubMed |
| The Implication of Androgens in the Presence of Protein Kinase C to Repair Alzheimer’s Disease-Induced Cognitive Dysfunction | Iran Biomed J | 2020 | 31677609 | PubTator, text mining | PubMed |
| Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery. | Curr Neuropharmacol | 2020 | 31362657 | PubTator, text mining | PubMed |
| The role of exosomal microRNAs; focus on clinical applications in breast cancer. | Cancer Drug Resist | 2019 | 35582569 | PubTator, text mining | PubMed |
| Sin1-mediated mTOR signaling in cell growth, metabolism and immune response. | Natl Sci Rev | 2019 | 34691993 | PubTator, text mining | PubMed |
| Simplified Model of PKCγ Signaling Dysregulation and Cytosol-to-Membrane Translocation Kinetics During Neurodegenerative Spinocerebellar Ataxia Type 14 (SCA14). | Front Neurosci | 2019 | 32082104 | PubTator, text mining | PubMed |
| Feedback Regulation of Syk by Protein Kinase C in Human Platelets. | Int J Mol Sci | 2019 | 31881809 | PubTator, text mining | PubMed |
| Pharmacogenomic Characterization in Bipolar Spectrum Disorders. | Pharmaceutics | 2019 | 31877761 | PubTator, text mining | PubMed |
| Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM proteogenomics sub-challenge. | BMC Bioinformatics | 2019 | 31861998 | PubTator, text mining | PubMed |
| Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells on Tumor Growth and Progression. | Adv Pharm Bull | 2019 | 31857958 | PubTator, text mining | PubMed |
| ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling. | Aging (Albany NY) | 2019 | 31848326 | PubTator, text mining | PubMed |
| Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype. | Int J Mol Sci | 2019 | 31835296 | PubTator, text mining | PubMed |
| Phosphoproteomic Landscaping Identifies Non-canonical cKIT Signaling in Polycythemia Vera Erythroid Progenitors. | Front Oncol | 2019 | 31824842 | PubTator, text mining | PubMed |
| Analysis of miRNA expression profiles in the liver of Clock Δ19 mutant mice. | PeerJ | 2019 | 31799078 | PubTator, text mining | PubMed |
| Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2. | Sci Rep | 2019 | 31784636 | PubTator, text mining | PubMed |
| Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer. | Front Oncol | 2019 | 31781506 | PubTator, text mining | PubMed |
| Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma. | J Cancer | 2019 | 31772663 | PubTator, text mining | PubMed |
| MARCKS protein overexpression is associated with poor prognosis in male breast cancer. | Cancer Biomark | 2019 | 31771045 | PubTator, text mining | PubMed |
| Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop. | J Extracell Vesicles | 2019 | 31762963 | PubTator, text mining | PubMed |
| Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer. | Mol Ther Nucleic Acids | 2019 | 31760377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4082/papers?page=44